Company Summary
DOD-R DOD BIOTECH PUBLIC COMPANY LIMITED
Consumer Products/
mai
CG Report:   
 
  Data as of 03 Dec 2021  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
11.00 15.80 / 8.20 N/A 3.66 205.00 4,510.01 4,798.41 268.34 16.57
News
Date/Time Subject
03 Dec 2021 08:44   Information Memorandum of Warrants to Purchase Newly Issued Ordinary Shares of DOD Biotech Public Company Limited No. 2 (DOD-W2)
03 Dec 2021 06:30   mai adds new listed securities : DOD-W2 to be traded on December 7, 2021
01 Dec 2021 07:06   Report on the results of the sale of warrants offered to existing common shareholders (F53-5)
11 Nov 2021 17:46   Financial Performance Quarter 3 (F45) (Reviewed)
11 Nov 2021 17:46   Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021
more

Company Profile
Address No. 111 Moo 2 Tha Chin Sub-district, Mueang Samut Sakhon District Samut Sakhon 74000
Telephone 0-3444-6333, 0-3444-6444
Fax 0-3444-0373
URL www.dodbiotech.com
  Annual Report 2020
Establish Date 11/02/2011 Listed Date 20/06/2018
IPO Price (Baht) 9.30 @Par0.50 Baht
IPO Financial Advisory
  • ADVISORY PLUS CO., LTD.
  • Par 0.50 Baht
    Last Par Change N/A

    Business
    DOD operates as a manufacturer of dietary supplement products under and customers' brand and its brand "Dai a to"

    Free Float 18 Mar 2021 02 Jun 2020
    % /Shareholders
    59.49% 12,815 39.13% 2,838
    Foreign Shareholders 2.13% (As of 03/12/2021) Foreign Limit 49.00%
    NVDR Shareholders  3.67% (As of 03/12/2021)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days -1.79 1.21 -0.92
    20 Days - 4.16 -4.50
    60 Days -10.57 -0.93 -15.97
    120 Days -15.38 -17.21 -25.83
    YTD 25.00 -20.54 -24.95
    P/E (X) N/A 20.28 56.22
    P/BV (X) 3.66 4.11 3.27
    Turnover Ratio (%) 0.22 0.38 0.87

    Top 10 Major Shareholders(@29 Oct 2021) Share %
    1. นาย ล้ำพันธุ์ พรรธนประเทศ 155,900,000 38.02
    2. นาย ดนุพล ชิลลี่ 19,976,800 4.87
    3. บริษัท Thai NVDR Company Limited 16,690,681 4.07
    4. MR. NOPARIT PUNTHITRA 6,260,900 1.53
    5. บริษัท ไทยประกันชีวิต จำกัด (มหาชน) 5,715,800 1.39
    6. นาย พงศ์ภน นันทราทิพย์ 5,582,000 1.36
    7. BBHISL NOMINEES LIMITED 4,603,200 1.12
    8. นาย CHAI MANOPHARS 4,480,000 1.09
    9. นาย สนิท ดุษฎีโหนด 3,438,800 0.84
    10. น.ส. THANYARAHT CHIDENSEA 3,200,000 0.78

    Management Position
    1. M.L. TERMSANG SUBPHASO CHAIRMAN / INDEPENDENT DIRECTOR
    2. Mr. THANIN SRISETHI EXECUTIVE CHAIRMAN / CHIEF EXECUTIVE OFFICER / DIRECTOR
    3. Mr. DUSIT CHONGSUTTHANAMANEE VICE CHAIRMAN OF THE BOARD OF DIRECTORS / INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
    4. Mr. WUTICHAI ANANTAKUL DIRECTOR
    5. Miss SUWARIN KONTHONG DIRECTOR
    6. Mr. AEKPHUSIT BOONSIRIYOTTHAKUL DIRECTOR
    7. Mr. PONGTEP THITHAPAND INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    8. Mrs. APAPORN KOSOLKUL INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    9. Mrs. SIEW SAN TAN INDEPENDENT DIRECTOR
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    03 Dec 2021
    2020
    30 Dec 2020
    2019
    30 Dec 2019
    Listed share (M.) 410.00  410.00  410.00 
    Market Cap (MB.) 4,510.01  3,608.00  2,993.00 
    Price (B./share) 11.00  8.80  7.30 
    BVPS (B./Share) 3.01  3.04  3.06 
    P/BV (X) 3.66  2.90  2.38 
    P/E (X) N/A  19.96  33.90 
    Turnover Ratio (%) 794.17  330.24  198.00 
    Value Trade/Day (MB.) 182.64  46.04  38.10 
    Beta 1.16  1.89  2.54 
     
    Rate of Return YTD  2020  2019 
    Price Change (%) 25.00  20.55  -46.32 
    Dividend Yield (%) N/A  3.98  6.03 
    Payout Ratio N/A  0.79  2.04 
    Dividend Policy Not exceeding 50% of the profits after deducting corporate income tax and reserves in pursuant to the laws (with additional conditions)

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2019 - 31 Dec 2019 0.35 Baht 20 May 2020 Cash
    01 Apr 2018 - 30 Sep 2018 0.44 Baht 18 Jan 2019 Cash
     
    Auditor
    (Effective Until 31/12/2021)
    MISS VISSUTA JARIYATHANAKORN/EY OFFICE LIMITED
    MRS. POONNARD PAOCHAROEN/EY OFFICE LIMITED
    Miss MANEE RATTANABUNNAKIT/EY OFFICE LIMITED
    F/S Year ended 31/12
    Latest Type of Report Unqualified opinion with an emphasis of matters
    Financial Data
    Statement of Financial Position (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Cash And Cash Equivalents 74.06 50.75 143.00 82.42 136.80
    A/R Net 290.40 248.30 280.62 231.72 71.95
    Inventories 136.06 258.17 246.33 114.52 24.62
    Current Assets 502.06 569.41 673.42 440.17 533.90
    PP&E Net 869.98 863.77 863.97 801.24 265.90
    Non-Current Assets 1,092.68 1,174.12 1,060.06 1,134.44 872.75
    Total Assets 1,594.74 1,743.54 1,733.48 1,574.61 1,406.64
    OD 88.52 77.95 130.39 93.15 10.00
    A/P Net 155.42 296.01 262.14 134.48 203.28
    Current portion of LT 30.56 39.13 39.58 48.68 -
    Current Liabilities 284.27 425.77 468.50 288.71 215.74
    Non-Current Liabilities 95.59 56.15 40.06 47.64 6.64
    Total Liabilities 379.85 481.92 508.55 336.35 222.39
    Authorized Capital 296.11 296.11 296.11 296.11 205.00
    Paid-Up Capital 205.00 205.00 205.00 205.00 205.00
    Premium (Discount) on Share Capital 890.58 939.87 939.87 939.87 939.87
    Retained Earnings (Deficit) 136.69 82.87 50.97 125.09 38.38
    Treasury Stock - - - - -
    Shares Of The Company Held By Subsidiaries - - - - -
    Other Components Of Equity - - - -68.82 1.01
     - Surplus (Deficits) - - - - -
    Shareholders' Equity 1,232.28 1,245.96 1,214.06 1,219.36 1,184.26
    Minority Interest -17.39 15.66 10.87 18.91 0.00
    more
    Statement of Comprehensive Income (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Revenue From Operations 787.68 1,163.60 1,611.20 789.92 666.36
    Other Income 1.72 7.84 9.39 6.01 6.76
    Total Revenues 789.57 1,171.65 1,620.84 797.50 673.12
    Costs 427.79 604.99 856.82 380.02 256.50
    Selling And Administrative Expenses 93.44 356.88 433.21 329.69 105.26
    Total Cost And Expenses 573.54 992.99 1,429.67 709.71 361.76
    EBITDA 268.34 232.28 253.48 142.26 333.01
    Depre. & Amor. 52.31 53.62 76.57 54.47 21.65
    EBIT 216.04 178.66 176.91 87.79 311.36
    Net Profit : Owners Of The Parent 19.29 173.14 141.25 86.71 305.26
    EPS (B.) 0.05 0.42 0.34 0.21 0.85
    more
    Statement of Cash Flow (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Operating Cash Flow 105.00 245.75 321.28 -42.77 64.89
    Investing Cash Flow -118.33 -104.21 -127.38 63.94 -733.13
    Financing Cash Flow -55.61 -173.20 -133.32 -75.56 693.14
    Net Cash Flow -68.94 -31.67 60.58 -54.38 24.89
    more
    Annualized: ROE, ROA
    Ratios 9M/2021  9M/2020  2020  2019 
    Current Ratio (X) 1.77 1.34 1.44 1.52
    ROE (%) -1.02 14.45 11.61 7.21
    ROA (%) 12.84 10.80 10.70 5.89
    D/E (X) 0.31 0.38 0.42 0.27
    Total Asset Turnover (X) 0.74 0.88 0.98 0.54
    Gross Profit Margin (%) 45.69 48.01 46.82 51.89
    EBIT Margin (%) 27.36 15.25 10.91 11.01
    Net Profit Margin (%) -1.26 14.50 8.22 9.22

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 9M/2021  9M/2020  2020  2019 
    Sales Growth -32.31 150.26 103.97 18.54
    COGs Growth -29.29 183.49 125.47 48.15
    Total Revenue Growth -32.61 148.50 103.24 18.48
    Total Expense Growth -42.24 161.15 101.44 96.18
    Net Profit Growth -88.86 118.93 62.90 -71.60

    Annualized
    Cash Cycle 9M/2021  9M/2020  2020  2019 
    A/R Turnover (Times) 4.59 6.17 6.29 5.20
    Avg. Collection Period (Days) 79.59 59.12 58.03 70.16
    Inventory Turnover (Times) 3.45 4.06 4.75 5.46
    Avg. Inventory Period (Days) 105.86 89.90 76.86 66.82
    A/P Turnover (Times) 3.01 3.68 4.32 2.25
    Avg. Payment Period (Days) 121.23 99.28 84.48 162.21
    Cash Cycle (Days) 64.23 49.73 50.42 -25.23


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    Cash Balance 10 May 2021 - 18 Jun 2021
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name -

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
     
    Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.